CME Group Overview
CME Group (CME) has a ROE of 16.11%, below the Finance sector average of 16.22%.
Get informed when a big investor buys or sells
+ Follow16.11%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CME Group's return on equity stands at 16.11%. That is below the Finance sector average of 16.22%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
CME Group sits lower the Finance benchmark (16.22%) with a ROE of 16.11%. That is roughly 0.7% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 16.11% for CME Group means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how CME Group's ROE evolved across reporting periods, while the comparison chart places CME next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Finance, ROE is commonly used to spot outliers. CME Group's reading of 16.11% (sector avg 16.22%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
